Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Ekso Bionics Holdings (EKSO) FCF Margin (2016 - 2025)

Historic FCF Margin for Ekso Bionics Holdings (EKSO) over the last 13 years, with Q3 2025 value amounting to 49.04%.

  • Ekso Bionics Holdings' FCF Margin rose 63000.0% to 49.04% in Q3 2025 from the same period last year, while for Sep 2025 it was 60.93%, marking a year-over-year decrease of 40500.0%. This contributed to the annual value of 55.14% for FY2024, which is 116700.0% up from last year.
  • According to the latest figures from Q3 2025, Ekso Bionics Holdings' FCF Margin is 49.04%, which was up 63000.0% from 169.37% recorded in Q2 2025.
  • Over the past 5 years, Ekso Bionics Holdings' FCF Margin peaked at 28.57% during Q4 2024, and registered a low of 169.37% during Q2 2025.
  • Its 5-year average for FCF Margin is 88.53%, with a median of 81.17% in 2021.
  • In the last 5 years, Ekso Bionics Holdings' FCF Margin soared by 705400bps in 2023 and then crashed by -1154300bps in 2025.
  • Ekso Bionics Holdings' FCF Margin (Quarter) stood at 75.42% in 2021, then crashed by -38bps to 104.11% in 2022, then surged by 68bps to 33.57% in 2023, then grew by 15bps to 28.57% in 2024, then crashed by -72bps to 49.04% in 2025.
  • Its FCF Margin was 49.04% in Q3 2025, compared to 169.37% in Q2 2025 and 58.52% in Q1 2025.